Medical News Today: Melanoma: Immunotherapy for brain metastases 'doubles survival'

A new study into U.S. cancer data finds that checkpoint blockade immunotherapy doubles median overall survival in melanoma patients with brain metastases.
Source: Feed1

Leave a Reply

Your email address will not be published. Required fields are marked *